Close Menu
    • Home
    • Contact Us
    Oman DiaryOman Diary
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • More
      • Sports
      • Technology
      • Travel
    Oman DiaryOman Diary
    Home » MAYPHARM Unveils HYALMASS AQUATOX, a Next-Generation Multi-Active Skin Solution for the Global Aesthetic Market
    PR Newswire

    MAYPHARM Unveils HYALMASS AQUATOX, a Next-Generation Multi-Active Skin Solution for the Global Aesthetic Market

    September 26, 2026
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    SEOUL, South Korea, Sept. 26, 2026 /PRNewswire/ — MAYPHARM, a global aesthetic and cosmeceutical company, has announced the upcoming launch of HYALMASS AQUATOX, introducing a new multi-active formulation designed to respond to the rapidly evolving demands of the global aesthetic market.

    Rather than relying on a single trending ingredient, HYALMASS AQUATOX brings together five high-interest active ingredients — PDRN, Exosomes, Botulinum Peptide, GHK-Cu, and Succinic Acid — in one advanced aesthetic formulation.

    Five Powerful Actives. One Advanced Formula.

    Botulinum Peptide — designed to support a smoother, more refined skin appearance
    GHK-Cu — a copper peptide widely studied for skin conditioning and regeneration-related applications
    Succinic Acid — recognized for its role in skin revitalization and antioxidant-related activity
    PDRN — associated with skin regeneration and recovery
    Exosomes — increasingly recognized for their role in advanced skin rejuvenation approaches

    By combining these highly sought-after ingredients, HYALMASS AQUATOX aims to address the growing global demand for multifunctional, ingredient-driven aesthetic solutions.

    A New Chapter for the HYALMASS Portfolio

    The launch follows the growing international interest in HYALMASS AQUA EXOSOME, strengthening MAYPHARM’s expanding presence in the global aesthetic market.

    As demand for advanced skin rejuvenation products continues to develop, the market has also seen an increasing number of products adopting similar ingredient concepts, visual identities, and positioning. MAYPHARM therefore emphasizes the importance of product authenticity and authorized distribution when purchasing HYALMASS products.

    Distributors, aesthetic professionals, and customers are encouraged to verify the original manufacturer, authorized supply channel, packaging, and official product information before purchasing or using HYALMASS products.

    Innovation That Moves With the Market

    With HYALMASS AQUATOX, MAYPHARM continues to expand its portfolio around emerging aesthetic trends while combining multiple high-interest actives into a single product concept.

    Five actives. One formula. A new direction for advanced skin care.

    HYALMASS AQUATOX — Coming Soon.

    Choose the Original. Choose MAYPHARM.

    Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/maypharm-unveils-hyalmass-aquatox-a-next-generation-multi-active-skin-solution-for-the-global-aesthetic-market-302890709.html

    Related Posts

    Abu Dhabi Finance Week 2026 Expands Global Reach with New Summits and Strategic Partnerships

    September 25, 2026

    Robo.ai Announces Groundbreaking for Phase I of ALIF Holding Group Industrial Park

    September 25, 2026

    EssentaTor EAC Fund Outlines Institutional Financial Architecture for Syria’s Economic Renewal at UAB Conference

    September 24, 2026

    Terrific Appoints Senior Havas Executive Alberto Canteli Suarez as President and Chief Commercial Officer

    September 24, 2026

    Football icon Luka Modrić joins Gorenje as brand ambassador

    September 24, 2026

    13th Silk Road International Film Festival Concludes in Xi’an with Golden Silk Road Awards Announced

    September 24, 2026
    Breaking News

    Asia-Pacific growth outlook lifted to 5% for 2026

    September 24, 2026

    UAE joins Trump meeting on Middle East security in New York

    September 23, 2026

    Egypt overseas transfers total $29.7 billion through July

    September 22, 2026

    Typhoon Dujuan brings flood risk and travel disruption

    September 21, 2026

    China keeps loan prime rates steady through September 2026

    September 21, 2026

    Rare EGFR mutation raises lung cancer risk 60 times in data

    September 19, 2026

    WHO reports Ebola progress as DR Congo outbreak continues

    September 17, 2026

    Gold prices decline on Federal Reserve rate decision in trading

    September 17, 2026
    © 2026 Oman Diary | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.